Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
54.16%
Operating Margin
19.84%
Net Margin
7.20%
Efficiency Metrics
Revenue per Expense Ratio
1.25
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
45.52%
Income Tax Rate
3.12%
EPS
0.5000000000
Balance Sheet Analysis
Current Ratio
4.13
Cash Ratio
2.39
Working Capital
$532.45M
Debt to Equity
2.30
Debt to Assets
53.78%
Equity Ratio
23.36%
Cash Flow Analysis
Operating Cash Flow Ratio
31.44%
Free Cash Flow Ratio
12.60%
CapEx to Revenue
18.84%
Dividends Paid
$26.89M
Stock Buybacks
$13.11M
Total Shareholder Returns
$39.99M
Cash Position Change
29.32%
Key Takeaways (2023 FY)
Increased dividend payments by 0.84%
Detailed Growth Metrics
Core Performance
Revenue
1.72%
Net Income
-15.77%
EPS
31.58%
Operating Income
15.49%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
3.52%
Operating Cash Flow
10.10%
Free Cash Flow
173.82%
Balance Sheet Health
Assets
1.34%
Debt
-0.26%
Book Value per Share
5.35%
Inventory
-100.00%
Shareholder Returns
Dividends per Share
0.84%
Shares Outstanding
-2.37%
Long Term Trends
3Y Revenue/Share
31.98%
5Y Revenue/Share
9.08%
3Y Dividend/Share
-29.36%
5Y Dividend/Share
-59.59%